about
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effectsNeuroimmune Interaction in the Regulation of Peripheral Opioid-Mediated Analgesia in InflammationIdentification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assayEnkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization studyCholecystokinin: a multi-functional molecular switch of neuronal circuits.Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs.Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future.Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.Screening inhibitors of anthrax lethal factor.Electroosmotic sampling. Application to determination of ectopeptidase activity in organotypic hippocampal slice cultures.Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.Contribution of Delta-Opioid Receptors to Pathophysiological Events Explored by Endogenous Enkephalins.Involvement of neuronal nitric oxide synthase in desensitisation of µ-opioid receptors in the rat locus coeruleus.In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position.Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.The state of GPCR research in 2004.Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2.
P2860
Q24543997-43278195-5FB7-4D67-AFDE-265CF00B178BQ26741108-6C44D444-80F1-4975-8DD7-04F1F1944B31Q33679572-A1FF96B4-A182-4234-B975-5EA7D17DD3D2Q34074610-2D1AA4E7-7D8D-45A7-92E6-06687DFCA46FQ34420892-A5B98AAA-D5AF-4760-A18C-D37B32CF7C4FQ34602588-61E84B19-CFF3-495F-8A85-93A96BAA5EA3Q35040802-DD18C496-31A8-4D71-9A22-7363D7DB34E5Q40263009-01BC48E5-CE7C-49D7-A689-F26DB101228AQ40715359-9A0D94D5-18D8-44F6-80F1-E398FB3206DBQ41901465-98D10E05-D673-468E-B508-02A8AF8F2E55Q42702528-BE94F268-E9B6-4666-9FC6-C829FB79A6CCQ42920341-BA7D76BA-B3AA-4558-9820-2BFA4D507A4CQ42948028-F1747A3C-FE2E-415F-981F-A7EAC69C6900Q43263146-4885A827-EA94-42EC-B00C-7DBDEB24EB70Q44338644-A8191BB7-8A26-477D-92E7-9FB256775588Q44345561-CF72DD62-7CBB-4A32-B9B9-751E98FE1321Q44792210-E578818B-1670-4EC9-A448-780B8DA86F80Q46575974-A1591675-EAC4-4DA1-AA4D-7DD9D8B23374Q55038697-DC4C2716-4F3A-415E-891D-8FA28D44F4DBQ55716780-0EDF1A0B-EC8D-4DB0-8EF6-B061288B7ADC
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Novel approaches to targeting neuropeptide systems.
@ast
Novel approaches to targeting neuropeptide systems.
@en
Novel approaches to targeting neuropeptide systems.
@nl
type
label
Novel approaches to targeting neuropeptide systems.
@ast
Novel approaches to targeting neuropeptide systems.
@en
Novel approaches to targeting neuropeptide systems.
@nl
prefLabel
Novel approaches to targeting neuropeptide systems.
@ast
Novel approaches to targeting neuropeptide systems.
@en
Novel approaches to targeting neuropeptide systems.
@nl
P1476
Novel approaches to targeting neuropeptide systems.
@en
P2093
B P Roques
P304
P356
10.1016/S0165-6147(00)01571-6
P577
2000-12-01T00:00:00Z